Crossmark

Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF

Published Online: 2021-02-27

Published Print: 2021-12

Authors

Bonella, Francesco https://orcid.org/0000-0001-7579-9767
Campo, Ilaria

Zorzetto, Michele

Boerner, Eda

Ohshimo, Shinichiro

Theegarten, Dirk

Taube, Christian

Costabel, Ulrich
Funding

Funding for this research was provided by:

Arbeitsgemeinschaft zur Förderung der Pneumologie an der Ruhrlandklinik

Universitätsklinikum Essen
License Information

Text and Data Mining valid from 2021-02-27

Version of Record valid from 2021-02-27
More Information

Article History

Received: 15 December 2020

Accepted: 16 February 2021

First Online: 27 February 2021

Ethics approval and consent to participate

: The experiments in this study comply with the current laws in Germany. The study was approved by the local IRB (20–9236-BO). Patients and healthy subjects provided written informed consent.

: Not applicable.

: The authors have reported that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.

Document is current